Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
Sports
Technology
History
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/61/40/19/6140199a-8721-a172-b247-eb9989975be9/mza_18046110378092382110.jpg/600x600bb.jpg
AUAUniversity
American Urological Association
410 episodes
1 day ago
AUA2025: Key Takeaways: Lower Urinary Tract Reconstruction Presenters: George E. Koch, MD & Kurt A. McCammon, MD, FACS
Show more...
Education
RSS
All content for AUAUniversity is the property of American Urological Association and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
AUA2025: Key Takeaways: Lower Urinary Tract Reconstruction Presenters: George E. Koch, MD & Kurt A. McCammon, MD, FACS
Show more...
Education
https://i1.sndcdn.com/artworks-fatupM6lMGlMlTqs-iUCtAw-t3000x3000.png
AUA2025: Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems
AUAUniversity
1 hour 52 minutes 1 second
4 months ago
AUA2025: Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems
AUA2025: Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems  CME Available: https://auau.auanet.org/node/43047 At the conclusion of this activity, participants will be able to: 1. Implement current practice guidelines and explain methods and resources to improve transurethral resection of a bladder tumor (TURBT) skills. 2. Identify the best intravesical agent and duration of therapy for low-, intermediate-, and high-risk NMIBC and what to do during a BCG shortage. 3. Identify methods to treat significant toxicities from various intravesical therapies. 4. Define high-risk scenarios that necessitate cystectomy and options for BCG-unresponsive disease. 5. Identify the scientific rationale for investigating immune oncology agents for BCG-unresponsive disease and become familiar with current clinical trial designs. ACKNOWLEDGEMENTS: This educational activity is supported by an independent educational grants from: Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
AUAUniversity
AUA2025: Key Takeaways: Lower Urinary Tract Reconstruction Presenters: George E. Koch, MD & Kurt A. McCammon, MD, FACS